Thrombin clinical trials
How each study uses Thrombin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Thrombin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 3 Feb 1986 · Thrombin-Jmi, Thrombocoll · BLA 102865 (FDA, Purple Book)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Thrombin
- 2
Studies by the year they started
3 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
NYU Langone Health (1) · University of Kansas Medical Center (1) · National Science Council, Taiwan (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Thrombin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated CoagulationNot yet recruitingPhase 4NYU Langone HealthNCT07644923Written as Thrombin
- Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior EpistaxisTerminatedNot applicableUniversity of Kansas Medical CenterNCT00814333Written as Thrombin-JMI
- A Prospective, Randomized Trial of Histoacryl Injection Versus Thrombin in the Control of Acute Gastric Variceal BleedingStatus unknownPhase 3National Science Council, TaiwanNCT01717612Written as Thrombin
As the comparator · 2 — what is tested is compared with Thrombin
Codes
What other systems call Thrombin · ClinicalTrials.gg INT008315
- MeSH (NLM) D013917ThrombinConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) 25ADE2236LTHROMBINConfirmed FDA, Wikidata
- RxNorm 10528One source FDA
- Wikidata Q409166Coagulation factor II, thrombinConfirmed FDA, Wikidata
- NCI Thesaurus C87773ThrombinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013917 | Thrombin | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | 25ADE2236L | THROMBIN | Confirmed FDA, Wikidata |
| RxNorm | 10528 | — | One source FDA |
| Wikidata | Q409166 | Coagulation factor II, thrombin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C87773 | Thrombin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.